These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791 [TBL] [Abstract][Full Text] [Related]
3. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428 [TBL] [Abstract][Full Text] [Related]
4. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859 [TBL] [Abstract][Full Text] [Related]
5. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII. Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345 [TBL] [Abstract][Full Text] [Related]
6. Intrinsic Thermodynamics and Structures of 2,4- and 3,4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases. Zubrienė A; Smirnov A; Dudutienė V; Timm DD; Matulienė J; Michailovienė V; Zakšauskas A; Manakova E; Gražulis S; Matulis D ChemMedChem; 2017 Jan; 12(2):161-176. PubMed ID: 28001003 [TBL] [Abstract][Full Text] [Related]
7. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII. Čapkauskaitė E; Baranauskienė L; Golovenko D; Manakova E; Gražulis S; Tumkevičius S; Matulis D Bioorg Med Chem; 2010 Nov; 18(21):7357-64. PubMed ID: 20926301 [TBL] [Abstract][Full Text] [Related]
8. Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII. Zubrienė A; Čapkauskaitė E; Gylytė J; Kišonaitė M; Tumkevičius S; Matulis D J Enzyme Inhib Med Chem; 2014 Feb; 29(1):124-31. PubMed ID: 23356363 [TBL] [Abstract][Full Text] [Related]
9. Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases. Čapkauskaitė E; Zubrienė A; Paketurytė V; Timm DD; Tumkevičius S; Matulis D Bioorg Chem; 2018 Apr; 77():534-541. PubMed ID: 29459130 [TBL] [Abstract][Full Text] [Related]
10. Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases. Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Kišonaitė M; Smirnov A; Manakova E; Gražulis S; Matulis D Eur J Med Chem; 2018 Aug; 156():61-78. PubMed ID: 30006175 [TBL] [Abstract][Full Text] [Related]
11. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057 [TBL] [Abstract][Full Text] [Related]
13. Saccharin sulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Morkūnaitė V; Baranauskienė L; Zubrienė A; Kairys V; Ivanova J; Trapencieris P; Matulis D Biomed Res Int; 2014; 2014():638902. PubMed ID: 25276805 [TBL] [Abstract][Full Text] [Related]
15. Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases. Vaškevičienė I; Paketurytė V; Pajanok N; Žukauskas Š; Sapijanskaitė B; Kantminienė K; Mickevičius V; Zubrienė A; Matulis D Bioorg Med Chem; 2019 Jan; 27(2):322-337. PubMed ID: 30553625 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]
18. Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors. Čapkauskaitė E; Zakšauskas A; Ruibys V; Linkuvienė V; Paketurytė V; Gedgaudas M; Kairys V; Matulis D Bioorg Med Chem; 2018 Feb; 26(3):675-687. PubMed ID: 29305297 [TBL] [Abstract][Full Text] [Related]
19. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]